Read + Share
Amedeo Smart
Independent Medical Education
Wang S, Xie T, Li Y, Guo L, et al. Low TP53 variant allele frequency as a biomarker for anti-programmed death (ligand) 1 monotherapy in lung adenocarcinoma. Cancer 2023;129:3873-3883.PMID: 37538036
Email
LinkedIn
Facebook
Twitter
Privacy Policy